We've found
312
archived clinical trials in
Food Studies
We've found
312
archived clinical trials in
Food Studies
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Updated: 12/31/1969
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma and Obesity Diet Versus Exercise
Updated: 12/31/1969
Obesity and Asthma: Determinants of Inflammation and Effect of Intervention
Status: Enrolling
Updated: 12/31/1969
Asthma and Obesity Diet Versus Exercise
Updated: 12/31/1969
Obesity and Asthma: Determinants of Inflammation and Effect of Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
Updated: 12/31/1969
An Open-label, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Oral CTAP101 (Calcifediol) Extended-release Capsules in Japanese and Non-Japanese Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
Updated: 12/31/1969
An Open-label, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Oral CTAP101 (Calcifediol) Extended-release Capsules in Japanese and Non-Japanese Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
Updated: 12/31/1969
Daily Ingestion of a Multi-Allergen Food Supplement by Infants: Clinical Symptoms, Reactions, and Acceptability - A Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
Updated: 12/31/1969
Daily Ingestion of a Multi-Allergen Food Supplement by Infants: Clinical Symptoms, Reactions, and Acceptability - A Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Food Allergy Diagnostic Test Response to Previous Oral Challenge Response
Updated: 12/31/1969
An Exploratory Pilot Study Evaluating the Correlation Between Conjunctival Allergen Challenge (CAC) Response to Dissolved Food Allergen and Previously Performed Oral Escalating Dose Food Challenge Response
Status: Enrolling
Updated: 12/31/1969
Food Allergy Diagnostic Test Response to Previous Oral Challenge Response
Updated: 12/31/1969
An Exploratory Pilot Study Evaluating the Correlation Between Conjunctival Allergen Challenge (CAC) Response to Dissolved Food Allergen and Previously Performed Oral Escalating Dose Food Challenge Response
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhibition of Anaphylaxis by Ibrutinib
Updated: 12/31/1969
Inhibition of Anaphylaxis by Ibrutinib
Status: Enrolling
Updated: 12/31/1969
Inhibition of Anaphylaxis by Ibrutinib
Updated: 12/31/1969
Inhibition of Anaphylaxis by Ibrutinib
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of a Diet Risk Screening Tool
Updated: 12/31/1969
Validation of a Diet Risk Screening Tool
Status: Enrolling
Updated: 12/31/1969
Validation of a Diet Risk Screening Tool
Updated: 12/31/1969
Validation of a Diet Risk Screening Tool
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nutrition Counseling to Lower Serum Phosphorus Levels
Updated: 2/23/2006
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated: 2/23/2006
Nutrition Counseling to Lower Serum Phosphorus Levels
Updated: 2/23/2006
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated: 2/23/2006
Click here to add this to my saved trials
Nutrition Counseling to Lower Serum Phosphorus Levels
Updated: 2/23/2006
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated: 2/23/2006
Nutrition Counseling to Lower Serum Phosphorus Levels
Updated: 2/23/2006
Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital
Status: Enrolling
Updated: 2/23/2006
Click here to add this to my saved trials
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Updated: 1/8/2008
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated: 1/8/2008
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Updated: 1/8/2008
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated: 1/8/2008
Click here to add this to my saved trials
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Updated: 1/8/2008
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated: 1/8/2008
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Updated: 1/8/2008
Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Status: Enrolling
Updated: 1/8/2008
Click here to add this to my saved trials
Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age
Updated: 7/30/2008
Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age
Status: Enrolling
Updated: 7/30/2008
Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age
Updated: 7/30/2008
Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age
Status: Enrolling
Updated: 7/30/2008
Click here to add this to my saved trials
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
Updated: 2/12/2009
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
Status: Enrolling
Updated: 2/12/2009
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
Updated: 2/12/2009
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
Status: Enrolling
Updated: 2/12/2009
Click here to add this to my saved trials
Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Population
Updated: 7/6/2009
Validation of the Malnutrition Screening Tool (MST) and Effectiveness of Oral Nutritional Supplements (ONS) on Weight, Nutritional Status and Quality of Life in a Meals-on-Wheels Population
Status: Enrolling
Updated: 7/6/2009
Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Population
Updated: 7/6/2009
Validation of the Malnutrition Screening Tool (MST) and Effectiveness of Oral Nutritional Supplements (ONS) on Weight, Nutritional Status and Quality of Life in a Meals-on-Wheels Population
Status: Enrolling
Updated: 7/6/2009
Click here to add this to my saved trials
Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
Updated: 3/23/2010
Pharmacokinetic Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
Status: Enrolling
Updated: 3/23/2010
Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
Updated: 3/23/2010
Pharmacokinetic Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
Status: Enrolling
Updated: 3/23/2010
Click here to add this to my saved trials
The Role of GLP-1 in Satiety Perception in Humans
Updated: 6/25/2010
The Role of GLP-1 in Satiety Perception in Humans
Status: Enrolling
Updated: 6/25/2010
The Role of GLP-1 in Satiety Perception in Humans
Updated: 6/25/2010
The Role of GLP-1 in Satiety Perception in Humans
Status: Enrolling
Updated: 6/25/2010
Click here to add this to my saved trials
Food Allergy - Tubes - Adenoids (FATA) Trial
Updated: 6/28/2010
A New Approach to Otitis Media With Effusion (OME)
Status: Enrolling
Updated: 6/28/2010
Food Allergy - Tubes - Adenoids (FATA) Trial
Updated: 6/28/2010
A New Approach to Otitis Media With Effusion (OME)
Status: Enrolling
Updated: 6/28/2010
Click here to add this to my saved trials
Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
Updated: 11/3/2010
Investigation of the Efficacy of the Food Allergy Herbal Formula (FAHF-2TM) in Patients With Food Allergy - Phase II Trial
Status: Enrolling
Updated: 11/3/2010
Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
Updated: 11/3/2010
Investigation of the Efficacy of the Food Allergy Herbal Formula (FAHF-2TM) in Patients With Food Allergy - Phase II Trial
Status: Enrolling
Updated: 11/3/2010
Click here to add this to my saved trials
Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
Updated: 11/3/2010
Investigation of the Efficacy of the Food Allergy Herbal Formula (FAHF-2TM) in Patients With Food Allergy - Phase II Trial
Status: Enrolling
Updated: 11/3/2010
Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
Updated: 11/3/2010
Investigation of the Efficacy of the Food Allergy Herbal Formula (FAHF-2TM) in Patients With Food Allergy - Phase II Trial
Status: Enrolling
Updated: 11/3/2010
Click here to add this to my saved trials
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Click here to add this to my saved trials
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Click here to add this to my saved trials
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Click here to add this to my saved trials
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777
Updated: 11/1/2011
Evaluation of an Oral Nutritional Supplement Containing AN777 in Malnourished and Frail Subjects
Status: Enrolling
Updated: 11/1/2011
Click here to add this to my saved trials
Extensively Hydrolyzed Formula: Hypoallergenicity
Updated: 3/15/2012
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
Status: Enrolling
Updated: 3/15/2012
Extensively Hydrolyzed Formula: Hypoallergenicity
Updated: 3/15/2012
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
Status: Enrolling
Updated: 3/15/2012
Click here to add this to my saved trials
Extensively Hydrolyzed Formula: Hypoallergenicity
Updated: 3/15/2012
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
Status: Enrolling
Updated: 3/15/2012
Extensively Hydrolyzed Formula: Hypoallergenicity
Updated: 3/15/2012
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
Status: Enrolling
Updated: 3/15/2012
Click here to add this to my saved trials
Extensively Hydrolyzed Formula: Hypoallergenicity
Updated: 3/15/2012
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
Status: Enrolling
Updated: 3/15/2012
Extensively Hydrolyzed Formula: Hypoallergenicity
Updated: 3/15/2012
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
Status: Enrolling
Updated: 3/15/2012
Click here to add this to my saved trials